Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make Evusheld available to immunocompromised patients on the NHS.

We continue to monitor promising compounds which can be used to prevent infection. While the evidence has most strongly supported the use of COVID-19 treatments rather than prophylaxis, we will keep this under review.

The Department has been assessing Evusheld, including requesting advice from clinicians on the most appropriate option for the National Health Service in line with available data, the public health situation and other treatments available. While we are considering the advice received, we are currently unable to confirm a specific timetable for any such decision.